View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, April 20 (HealthDay News) -- The rate of triple-class virological failure to three or more antiretroviral therapy (ART) drugs in children infected perinatally with HIV is low, but higher than the rate in adults, according to a study published online April 20 in The Lancet.
Hannah Castro, and colleagues from the Pursuing Later Treatment Options II project, investigated the rate and predictors of triple-class virological failure to three or more ART drugs in 1,007 HIV-infected children who were younger than 16 years of age within the Collaboration of Observational HIV Epidemiological Research Europe. Participants started ART with three or more drugs between 1998 and 2008, and were followed up for an average of 4.2 years.
The investigators found that 237 children (24 percent) were triple-class exposed, and 105 (10 percent) experienced triple-class virological failure, 29 of whom had never had a viral-load measurement lower than 500 copies per ml. The incidence of triple-class virological failure increased with time after ART initiation, reaching 12 percent by five years after initiation. ART initiation at older age was significantly correlated with elevated risk of viral failure. The rate of failure was higher in 686 children starting ART with nucleotide reverse transcriptase inhibitors (NRTIs), and either a non-NRTI or ritonavir-boosted protease inhibitor, than in adults with heterosexually transmitted HIV (hazard ratio, 2.2).
"Early identification of children not responding to ART, adherence support, particularly for children and adolescents aged 13 years or older starting ART, and ART simplification strategies are all needed to attain and sustain virological suppression," the authors write.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top